|
FAM185A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.160020E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.227300E-04 |
| Normal-vs-Stage2 |
1.117790E-01 |
| Normal-vs-Stage3 |
5.026200E-01 |
| Normal-vs-Stage4 |
2.313000E-01 |
| Stage1-vs-Stage2 |
3.341800E-01 |
| Stage1-vs-Stage3 |
1.006100E-02 |
| Stage1-vs-Stage4 |
2.877900E-02 |
| Stage2-vs-Stage3 |
8.454400E-02 |
| Stage2-vs-Stage4 |
5.488000E-02 |
| Stage3-vs-Stage4 |
5.646000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.574600E-04 |
| Normal-vs-AfricanAmerican |
1.792210E-02 |
| Normal-vs-Asian |
5.405400E-01 |
| Caucasian-vs-AfricanAmerican |
3.125600E-01 |
| Caucasian-vs-Asian |
8.240400E-01 |
| AfricanAmerican-vs-Asian |
6.587600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.022600E-04 |
| Normal-vs-Female |
1.757730E-02 |
| Male-vs-Female |
5.075200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.335800E-01 |
| Normal-vs-Extreme_Weight |
6.864400E-03 |
| Normal-vs-Obese |
4.306400E-02 |
| Normal-vs-Extreme_Obese |
3.117000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.114200E-01 |
| Normal_Weight-vs-Obese |
2.011200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.064600E-01 |
| Extreme_Weight-vs-Obese |
7.217800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.293800E-01 |
| Obese-vs-Extreme_Obese |
8.268600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.812140E-02 |
| Normal-vs-Age(41-60Yrs) |
1.369910E-04 |
| Normal-vs-Age(61-80Yrs) |
7.543900E-03 |
| Normal-vs-Age(81-100Yrs) |
6.787200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.352400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.830000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.017600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.977000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.404800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.104000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.71799996451227E-09 |
| Normal-VS-Type2 PRCC |
3.097000E-01 |
| Normal-VS-KIRP CIMP |
9.998900E-03 |
| Normal-VS-Unclassified PRCC |
1.748610E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.56190005373702E-09 |
| Type1 PRCC-VS-KIRP CIMP |
3.8523000000068E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
3.120500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.782400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.532300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.865800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.935000E-01 |
| Normal-vs-N1 |
7.427800E-02 |
| Normal-vs-N2 |
3.545700E-02 |
| N0-vs-N1 |
1.217400E-01 |
| N0-vs-N2 |
2.404200E-01 |
| N1-vs-N2 |
5.228000E-01 |
|
|
